Werewolf Therapeutics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 200 TALCOTT AVENUE, WATERTOWN, MA, 02472
Mailing Address 200 TALCOTT AVENUE, WATERTOWN, MA, 02472
Phone 617-952-0555
Fiscal Year End 1231
EIN 823523180
Financial Overview
FY2024
$63.46M
Total Liabilities
$122.34M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | December 29, 2025 | View on SEC |
Material Events
8-K Financial Distress February 13, 2026
High Impact
- Prioritizing most advanced proprietary INDUKINE™ programs, WTX-124 and WTX-330, currently in preclinical development.
- Actively seeking strategic partnerships, collaborations, or out-licensing opportunities for core programs to maximize value.
8-K Financial Distress February 6, 2026
High Impact
- Werewolf Therapeutics has 180 calendar days, until August 3, 2026, to regain Nasdaq compliance by maintaining a stock price of $1.00 or more for 10 consecutive business days.
- The company may qualify for a second 180-day compliance period if it meets other listing standards, offering an extended timeframe to resolve the issue.
Insider Trading
STRONG SELL 3 insiders
63 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.